LFCR — Lifecore Biomedical Share News
0.000.00%
Last trade - 00:00- $242.60m
- $380.42m
- $128.87m
Brief: Lifecore Biomedical Inc Says Co Agreed To Sell An Aggregate Of 627,746 Shares Of Its Common For Aggregate Gross Proceeds Of About $5.0 Million
Brief: Landec To Change Corporate Name To Lifecore Biomedical And Ticker Symbol To “Lfcr” On November 14
U.S. RESEARCH ROUNDUP- Abiomed, Dexcom, Stryker
Landec Corp reports results for the quarter ended in August - Earnings Summary
Brief: Landec Corporation Reports First Quarter Fiscal Year 2023 Results
Landec Corp expected to post a loss of 13 cents a share - Earnings Preview
Brief: 22NW Fund LP Reports 6% Passive Stake In Landec Corp As Of August 31
Brief: Landec Corp Receives Notice From Nasdaq Regarding Delayed Annual Report
Landec Corp reports results for the quarter ended in May - Earnings Summary
Brief: Landec Corporation Reports Fourth Quarter And Full Fiscal Year 2022 Results
Brief: Landec Corporation Announces Intention To Become Lifecore Biomedical
Landec Corp expected to post a loss of 1 cent a share - Earnings Preview
Landec Corp expected to post a loss of 1 cent a share - Earnings Preview
Landec Corp reports results for the quarter ended in February - Earnings Summary
Brief: Landec Corp Reiterates Fiscal 2022 Full Year Guidance
Landec Corp expected to post breakeven results a share - Earnings Preview
Brief: Landec Increases Size Of Board To 11 Members, Elects Ray Diradoorian To Serve As Board Member
Landec Corp reports results for the quarter ended in November - Earnings Summary
Brief: Landec Corporation Reports Second Quarter Fiscal Year 2022 Results